NRAS and melanoma: NRAS ASO-1 treatment did not significantly reduce cell growth in primary human melanocytes (the cell type that melanoma derives from), primary human liver cells, epithelial human colon cells, or NRAS-WT melanoma cells (Fig. 3c).